OGT Receives ISO/IEC 27001:2005 Accreditation
Oxford Gene Technology (OGT) announced that it has been certified compliant with ISO/IEC 27001:2005, an international information security management standard. Extending to all data generation and security procedures, including OGT’s CytoSure™ and Genefficiency™ services, biomarker discovery solutions, and the development of CytoSure Interpret software, this certification acknowledges that data confidentiality, availability and integrity is carefully managed and controlled.
Dr Mike Evans, OGT’s CEO, commented: “Being one of only 448 companies within the UK to be compliant with ISO/IEC 27001:2005 demonstrates our ongoing commitment to information security and confidentiality. It also emphasises the dedication and reliability of our team to provide high-quality products and services, while protecting the integrity and confidentiality of all information and data.”
The ISO/IEC 27001:2005 certification was awarded following an assessment by the British Standards Institution (BSI).
Organizations
Other news from the department politics & laws
These products might interest you

Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management

ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Levels of 'Molly,' aka ecstasy, spike in rivers near music festival - Concerts and other large events are associated with increased levels of drugs such as "Molly" in nearby bodies of water.

Ångström-Resolution Fluorescence Microscopy - This innovation is poised to usher in a paradigm shift in our approach to study biological systems with thus far unprecedented detail

The gut may be involved in the development of multiple sclerosis

Anti-aging molecule NAD+ gets a boost from blocking an enzyme
Keeping stem cells from changing fates
Nanoparticles that could specifically target and kill only cancerous cells

Making the gray cells happy - Neutrons show a connection between lithium concentration and depression

A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Time - Helmholtz Munich and TU Munich further develop method together with spin-off iThera Medical

As easy as Googling - AI finds the right substances - Chemspace and PharmAI collaborate to make the world's largest online catalog of small molecules and biologics even more user-friendly

Interrogating disease progression and cell processes with TIGER: in vivo and non-invasively - Peering into the cellular past: Technology records ribonucleic acids in individual living cells.
New data support efficacy of Ruconest across all HAE attack locations
